News Releases

January 2019

January 8, 2019 1/8/2019 Takeda Completes Acquisition of Shire, Becoming a Global, Values-based, R&D-Driven Biopharmaceutical Leader

January 6, 2019 1/6/2019 Notice Regarding the Determination of Subscription Requirements to Issue New Takeda Shares

January 3, 2019 1/3/2019 Takeda Announces Multiple Cell Therapy Collaborations to Advance the Company’s Novel Immuno-Oncology Portfolio

January 3, 2019 1/3/2019 Takeda Notes Court Sanction of the Scheme of Arrangement with respect to the Acquisition of Shire plc

December 2018

December 21, 2018 12/21/2018 Takeda Announces Cancellation of Remaining Commitments under the Bridge Credit Agreement in Connection with the Proposed Acquisition of Shire plc

December 18, 2018 12/18/2018 Takeda Announces Listing of American Depository Shares on the New York Stock Exchange

December 14, 2018 12/14/2018 Takeda Receives Positive CHMP Opinion for ADCETRIS®

December 12, 2018 12/12/2018 Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners

December 12, 2018 12/12/2018 GARDP, Eisai and Takeda announce partnership in the search for new antibiotics

・For legacy Shire information, click here